Molecular nutrition research-The modern way of performing nutritional science

Nutrients

Volumn 4, Issue 12, 2012, Pages 1898-1944

  Norheim, Frode ^a   Gjelstad, Ingrid Merethe Fange ^a   Hjorth, Marit ^a   Vinknes, Kathrine J ^a   Langleite, Torgrim M ^a   Holen, Torgeir ^a   Jensen, Jørgen ^b   Dalen, Knut Tomas ^a   Karlsen, Anette S ^a   Kielland, Anders ^a   Rustan, Arild C ^c   Drevon, Christian A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Adipokines; Genomics; Metabolomics; Molecular nutrition; Myokines; Nutrigenomics; Proteomics; Systems biology; Transcriptomics

Indexed keywords

ICOSANOID; LIGAND; POLYUNSATURATED FATTY ACID; TRANSCRIPTION FACTOR;

ACYLATION; ADIPOSE TISSUE; CALORIMETRY; DIET; DIET RESTRICTION; DIETARY INTAKE; ENERGY EXPENDITURE; ENZYME SPECIFICITY; EPIDEMIOLOGY; EPIGENETICS; EXERCISE; FATTY ACID METABOLISM; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GLUCOSE TOLERANCE TEST; HUMAN; INTESTINE FLORA; LIPID PEROXIDATION; LIVER; MEAL; MEDICAL RESEARCH; MEMBRANE FLUIDITY; METABOLOMICS; MOLECULAR IMAGING; MOLECULAR NUTRITION; NONHUMAN; NUTRIGENOMICS; NUTRITION; NUTRITIONAL SCIENCE; OBESITY; PROTEOMICS; REVIEW; RISK FACTOR; SKELETAL MUSCLE; SYSTEMS BIOLOGY; TRANSCRIPTOMICS;

EID: 84870718527     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu4121898     Document Type: Review

References (226)

1. Karkanas, P.; Shahack-Gross, R.; Ayalon, A.; Bar-Matthews, M.; Barkai, R.; Frumkin, A.; Gopher, A.; Stiner, M.C. Evidence for habitual use of fire at the end of the Lower Paleolithic: Site-formation processes at Qesem Cave, Israel. J. Hum. Evol. 2007, 53, 197-212.
2. Weiner, S.; Xu, Q.; Goldberg, P.; Liu, J.; Bar-Yosef, O. Evidence for the use of fire at Zhoukoudian, China. Science 1998, 281, 251-253.
3. Gupta, A.K. Origin of agriculture and domestication of plants and animals linked to early Holocene climate amelioration. Curr. Sci. 2004, 87, 54-59.
4. Bloom, D.E. 7 billion and counting. Science 2011, 333, 562-569.
5. Bocquet-Appel, J.P. When the world's population took off: The springboard of the Neolithic demographic transition. Science 2011, 333, 560-561.
6. World Population Prospects, the 2010 Revision. Available online: http://esa.un.org/unpd/wpp/index.htm (accessed on 15 November 2012).
7. Statistics Norway. Available online: http://www.ssb.no (accessed on 15 November 2012).
8. Van Ommen, B.; Bouwman, J.; Dragsted, L.O.; Drevon, C.A.; Elliott, R.; de Groot, P.; Kaput, J.; Mathers, J.C.; Muller, M.; Pepping, F. et al. Challenges of molecular nutrition research 6: The nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes Nutr. 2010, 5, 189-203.
9. Frequently Asked Questions about Genetic and Genomic Science. Available online: http://www.genome.gov/19016904 (accessed on 15 November 2012).
10. Muller, M.; Kersten, S. Nutrigenomics: Goals and strategies. Nat. Rev. Genet. 2003, 4, 315-322.
11. Afman, L.; Muller, M. Nutrigenomics: From molecular nutrition to prevention of disease. J. Am. Diet. Assoc. 2006, 106, 569-576.
12. Nutrigenomics Organisation Homepage. Available online: http://www.nugo.org/everyone (accessed on 15 November 2012).
13. Rustan, A.C.; Drevon, C.A. Fatty Acids: Structures and Properties; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2001.
14. Hihi, A.K.; Michalik, L.; Wahli, W. PPARs: Transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 2002, 59, 790-798.
15. Schoonjans, K.; Staels, B.; Auwerx, J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996, 37, 907-925.
16. De Roos, B.; Mavrommatis, Y.; Brouwer, I.A. Long-chain n-3 polyunsaturated fatty acids: New insights into mechanisms relating to inflammation and coronary heart disease. Br. J. Pharmacol. 2009, 158, 413-428.
17. Rustan, A.C.; Nossen, J.O.; Osmundsen, H.; Drevon, C.A. Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J. Biol. Chem. 1988, 263, 8126-8132.
18. Rustan, A.C.; Nossen, J.O.; Christiansen, E.N.; Drevon, C.A. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J. Lipid Res. 1988, 29, 1417-1426.
19. Leikin, A.I.; Brenner, R.R. Microsomal delta 5 desaturation of eicosa-8,11,14-trienoic acid is activated by a cytosolic fraction. Lipids 1989, 24, 101-104.
20. Nenseter, M.S.; Rustan, A.C.; Lund-Katz, S.; Soyland, E.; Maelandsmo, G.; Phillips, M.C.; Drevon, C.A. Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Arterioscler. Thromb. 1992, 12, 369-379.
21. Brude, I.R.; Drevon, C.A.; Hjermann, I.; Seljeflot, I.; Lund-Katz, S.; Saarem, K.; Sandstad, B.; Solvoll, K.; Halvorsen, B.; Arnesen, H.; Nenseter, M.S. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2576-2588.
22. Triola, G.; Waldmann, H.; Hedberg, C. Chemical biology of lipidated proteins. ACS Chem. Biol. 2012, 7, 87-99.
23. Muszbek, L.; Laposata, M. Covalent modification of proteins by arachidonate and eicosapentaenoate in platelets. J. Biol. Chem. 1993, 268, 18243-18248.
24. Morine, M.J.; Tierney, A.C.; van Ommen, B.; Daniel, H.; Toomey, S.; Gjelstad, I.M.; Gormley, I.C.; Perez-Martinez, P.; Drevon, C.A.; Lopez-Miranda, J.; Roche, H.M. Transcriptomic coordination in the human metabolic network reveals links between n-3 fat intake, adipose tissue gene expression and metabolic health. PLoS Comput. Biol. 2011, 7, e1002223.
25. Willett, W. Nutritional Epidemiology; Oxford University Press: New York, NY, USA, 1998.
26. Sempos, C.T.; Liu, K.; Ernst, N.D. Food and nutrient exposures: What to consider when evaluating epidemiologic evidence. Am. J. Clin. Nutr. 1999, 69, 1330S-1338S.
27. Margetts, B.; Nelson, M. Design Concepts in Nutritional Epidemiology; Oxford University Press: New York, NY, USA, 1997.
28. Jeffery, E.H.; Keck, A.S. Translating knowledge generated by epidemiological and in vitro studies into dietary cancer prevention. Mol. Nutr. Food Res. 2008, 52, S7-S17.
29. Fowke, J.H.; Schlundt, D.; Gong, Y.; Jin, F.; Shu, X.O.; Wen, W.; Liu, D.K.; Gao, Y.T.; Zheng, W. Impact of season of food frequency questionnaire administration on dietary reporting. Ann. Epidemiol. 2004, 14, 778-785.
30. Palaniappan, U.; Cue, R.I.; Payette, H.; Gray-Donald, K. Implications of day-to-day variability on measurements of usual food and nutrient intakes. J. Nutr. 2003, 133, 232-235.
31. Murtaugh, M.A.; Herrick, J.S.; Sweeney, C.; Baumgartner, K.B.; Guiliano, A.R.; Byers, T.; Slattery, M.L. Diet composition and risk of overweight and obesity in women living in the southwestern United States. J. Am. Diet. Assoc. 2007, 107, 1311-1321.
32. Rosell, M.; Appleby, P.; Spencer, E.; Key, T. Weight gain over 5 years in 21,966 meat-eating, fish-eating, vegetarian, and vegan men and women in EPIC-Oxford. Int. J. Obes. (Lond.) 2006, 30, 1389-1396.
33. Spencer, E.A.; Appleby, P.N.; Davey, G.K.; Key, T.J. Diet and body mass index in 38,000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 728-734.
34. El-Khairy, L.; Ueland, P.M.; Nygard, O.; Refsum, H.; Vollset, S.E. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: The Hordaland Homocysteine Study. Am. J. Clin. Nutr. 1999, 70, 1016-1024.
35. Elshorbagy, A.K.; Nurk, E.; Gjesdal, C.G.; Tell, G.S.; Ueland, P.M.; Nygard, O.; Tverdal, A.; Vollset, S.E.; Refsum, H. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: Does cysteine link amino acid and lipid metabolism? Am. J. Clin. Nutr. 2008, 88, 738-746.
36. Elshorbagy, A.K.; Valdivia-Garcia, M.; Refsum, H.; Butte, N. The association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescents. PloS One 2012, 7, e44166.
37. Pereira da Silva, N.; Suano de Souza, F.I.; Ifanger Pendezza, A.; Luiz Affonso Fonseca, F.; Hix, S.; Oliveira, A.C.; Oselka Saccardo Sarni, R.; D'Almeida, V. Homocysteine and cysteine levels in prepubertal children: Association with waist circumference and lipid profile. Nutrition 2012, doi:10.1016/j.nut.2012.05.015.
38. Olefsky, J.M. Comparison of the effects of insulin and insulin-like agents on different aspects of adipocyte metabolism. Horm. Metab. Res. 1979, 11, 209-213.
39. Czech, M.P.; Fain, J.N. Antagonism of insulin action on glucose metabolism in white fat cells by dexamethasone. Endocrinology 1972, 91, 518-522.
40. Elshorbagy, A.K.; Church, C.; Valdivia-Garcia, M.; Smith, A.D.; Refsum, H.; Cox, R. Dietary cystine level affects metabolic rate and glycaemic control in adult mice. J. Nutr. Biochem. 2012, 23, 332-340.
41. Elshorbagy, A.K.; Valdivia-Garcia, M.; Mattocks, D.A.; Plummer, J.D.; Smith, A.D.; Drevon, C.A.; Refsum, H.; Perrone, C.E. Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase. J. Lipid Res. 2011, 52, 104-112.
42. Vang, A.; Singh, P.N.; Lee, J.W.; Haddad, E.H.; Brinegar, C.H. Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: Findings from Adventist Health Studies. Ann. Nutr. Metab. 2008, 52, 96-104.
43. Mudd, S.H.; Levy, H.L.; Skovby, F. Disorders of Transsulfuration; McGraw-Hill, Inc.: New York, NY, USA, 1995.
44. Pogribna, M.; Melnyk, S.; Pogribny, I.; Chango, A.; Yi, P.; James, S.J. Homocysteine metabolism in children with Down syndrome: In vitro modulation. Am. J. Hum. Genet. 2001, 69, 88-95.
45. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M.; Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114, 1752-1761.
46. Elshorbagy, A.K.; Kozich, V.; Smith, A.D.; Refsum, H. Cysteine and obesity: Consistency of the evidence across epidemiologic, animal and cellular studies. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 49-57.
47. Carlson, C.S.; Eberle, M.A.; Kruglyak, L.; Nickerson, D.A. Mapping complex disease loci in whole-genome association studies. Nature 2004, 429, 446-452.
48. Hirschhorn, J.N.; Daly, M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 2005, 6, 95-108.
49. Manning, A.K.; Hivert, M.F.; Scott, R.A.; Grimsby, J.L.; Bouatia-Naji, N.; Chen, H.; Rybin, D.; Liu, C.T.; Bielak, L.F.; Prokopenko, I. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 2012, 44, 659-669.
50. Speliotes, E.K.; Willer, C.J.; Berndt, S.I.; Monda, K.L.; Thorleifsson, G.; Jackson, A.U.; Allen, H.L.; Lindgren, C.M.; Luan, J.; Magi, R. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 2010, 42, 937-948.
51. MacLellan, W.R.; Wang, Y.; Lusis, A.J. Systems-based approaches to cardiovascular disease. Nat. Rev. Cardiol. 2012, 9, 172-184.
52. Bennett, B.J.; Farber, C.R.; Orozco, L.; Kang, H.M.; Ghazalpour, A.; Siemers, N.; Neubauer, M.; Neuhaus, I.; Yordanova, R.; Guan, B. et al. A high-resolution association mapping panel for the dissection of complex traits in mice. Genome Res. 2010, 20, 281-290.
53. Ghazalpour, A.; Rau, C.D.; Farber, C.R.; Bennett, B.J.; Orozco, L.D.; van Nas, A.; Pan, C.; Allayee, H.; Beaven, S.W.; Civelek, M. et al. Hybrid mouse diversity panel: A panel of inbred mouse strains suitable for analysis of complex genetic traits. Mamm. Genome 2012, 23, 680-692.
54. Giovannini, M.; Verduci, E.; Salvatici, E.; Paci, S.; Riva, E. Phenylketonuria: Nutritional advances and challenges. Nutr. Metab. 2012, 9, doi:10.1186/1743-7075-9-7.
55. Frayling, T.M.; Timpson, N.J.; Weedon, M.N.; Zeggini, E.; Freathy, R.M.; Lindgren, C.M.; Perry, J.R.; Elliott, K.S.; Lango, H.; Rayner, N.W. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316, 889-894.
56. Scuteri, A.; Sanna, S.; Chen, W.M.; Uda, M.; Albai, G.; Strait, J.; Najjar, S.; Nagaraja, R.; Orru, M.; Usala, G. et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007, 3, e115.
57. Tung, Y.C.; Yeo, G.S. From GWAS to biology: Lessons from FTO. Ann. N. Y. Acad. Sci. 2011, 1220, 162-171.
58. Moleres, A.; Ochoa, M.C.; Rendo-Urteaga, T.; Martinez-Gonzalez, M.A.; Azcona San Julian, M.C.; Martinez, J.A.; Marti, A. Dietary fatty acid distribution modifies obesity risk linked to the rs9939609 polymorphism of the fat mass and obesity-associated gene in a Spanish case-control study of children. Br. J. Nutr. 2012, 107, 533-538.
59. Phillips, C.M.; Kesse-Guyot, E.; McManus, R.; Hercberg, S.; Lairon, D.; Planells, R.; Roche, H.M. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. J. Nutr. 2012, 142, 824-831.
60. Kilpelainen, T.O.; Qi, L.; Brage, S.; Sharp, S.J.; Sonestedt, E.; Demerath, E.; Ahmad, T.; Mora, S.; Kaakinen, M.; Sandholt, C.H. et al. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011, 8, e1001116.
61. Barker, D.J.; Osmond, C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1, 1077-1081.
62. Painter, R.C.; de Rooij, S.R.; Bossuyt, P.M.; Simmers, T.A.; Osmond, C.; Barker, D.J.; Bleker, O.P.; Roseboom, T.J. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am. J. Clin. Nutr. 2006, 84, 322-327.
63. Ruemmele, F.M.; Garnier-Lengline, H. Why are genetics important for nutrition? Lessons from epigenetic research. Ann. Nutr. Metab. 2012, 60, 38-43.
64. Handel, A.E.; Ebers, G.C.; Ramagopalan, S.V. Epigenetics: Molecular mechanisms and implications for disease. Trends Mol. Med. 2010, 16, 7-16.
65. Cedar, H.; Bergman, Y. Linking DNA methylation and histone modification: Patterns and paradigms. Nat. Rev. Genet. 2009, 10, 295-304.
66. Fraga, M.F.; Ballestar, E.; Paz, M.F.; Ropero, S.; Setien, F.; Ballestar, M.L.; Heine-Suner, D.; Cigudosa, J.C.; Urioste, M.; Benitez, J. et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 2005, 102, 10604-10609.
67. Milagro, F.I.; Campion, J.; Cordero, P.; Goyenechea, E.; Gomez-Uriz, A.M.; Abete, I.; Zulet, M.A.; Martinez, J.A. A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight loss. FASEB J. 2011, 25, 1378-1389.
68. Ling, C.; Poulsen, P.; Simonsson, S.; Ronn, T.; Holmkvist, J.; Almgren, P.; Hagert, P.; Nilsson, E.; Mabey, A.G.; Nilsson, P. et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 2007, 117, 3427-3435.
69. Mootha, V.K.; Lindgren, C.M.; Eriksson, K.F.; Subramanian, A.; Sihag, S.; Lehar, J.; Puigserver, P.; Carlsson, E.; Ridderstrale, M.; Laurila, E. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34, 267-273.
70. Patti, M.E.; Butte, A.J.; Crunkhorn, S.; Cusi, K.; Berria, R.; Kashyap, S.; Miyazaki, Y.; Kohane, I.; Costello, M.; Saccone, R. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100, 8466-8471.
71. Barres, R.; Osler, M.E.; Yan, J.; Rune, A.; Fritz, T.; Caidahl, K.; Krook, A.; Zierath, J.R. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009, 10, 189-198.
72. Barres, R.; Yan, J.; Egan, B.; Treebak, J.T.; Rasmussen, M.; Fritz, T.; Caidahl, K.; Krook, A.; O'Gorman, D.J.; Zierath, J.R. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012, 15, 405-411.
73. Katari, S.; Turan, N.; Bibikova, M.; Erinle, O.; Chalian, R.; Foster, M.; Gaughan, J.P.; Coutifaris, C.; Sapienza, C. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum. Mol. Genet. 2009, 18, 3769-3778.
74. Morgan, H.D.; Sutherland, H.G.; Martin, D.I.; Whitelaw, E. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 1999, 23, 314-318.
75. Wolff, G.L.; Kodell, R.L.; Moore, S.R.; Cooney, C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998, 12, 949-957.
76. Ng, S.F.; Lin, R.C.; Laybutt, D.R.; Barres, R.; Owens, J.A.; Morris, M.J. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010, 467, 963-966.
77. Godfrey, K.M.; Sheppard, A.; Gluckman, P.D.; Lillycrop, K.A.; Burdge, G.C.; McLean, C.; Rodford, J.; Slater-Jefferies, J.L.; Garratt, E.; Crozier, S.R. et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011, 60, 1528-1534.
78. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
79. Kallio, P.; Kolehmainen, M.; Laaksonen, D.E.; Kekalainen, J.; Salopuro, T.; Sivenius, K.; Pulkkinen, L.; Mykkanen, H.M.; Niskanen, L.; Uusitupa, M.; Poutanen, K.S. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: The FUNGENUT Study. Am. J. Clin. Nutr. 2007, 85, 1417-1427.
80. Zhang, L.; Hou, D.; Chen, X.; Li, D.; Zhu, L.; Zhang, Y.; Li, J.; Bian, Z.; Liang, X.; Cai, X. et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res. 2012, 22, 107-126.
81. Panagiotou, G.; Nielsen, J. Nutritional systems biology: Definitions and approaches. Ann. Rev. Nutr. 2009, 29, 329-339.
82. Crujeiras, A.B.; Parra, D.; Milagro, F.I.; Goyenechea, E.; Larrarte, E.; Margareto, J.; Martinez, J.A. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: A nutrigenomics study. OMICS 2008, 12, 251-261.
83. Caesar, R.; Manieri, M.; Kelder, T.; Boekschoten, M.; Evelo, C.; Muller, M.; Kooistra, T.; Cinti, S.; Kleemann, R.; Drevon, C.A. A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One 2010, 5, e11525.
84. Henze, A.; Rohn, S.; Gericke, B.; Raila, J.; Schweigert, F.J. Structural modifications of serum transthyretin in rats during protein-energy malnutrition. Rapid Commun. Mass Spectrom. 2008, 22, 3270-3274.
85. Romagnolo, D.F.; Milner, J.A. Opportunities and challenges for nutritional proteomics in cancer prevention. J. Nutr. 2012, 142, 1360S-1369S.
86. Kussmann, M.; Panchaud, A.; Affolter, M. Proteomics in nutrition: Status quo and outlook for biomarkers and bioactives. J. Proteome Res. 2010, 9, 4876-4887.
87. Moore, J.B.; Weeks, M.E. Proteomics and systems biology: Current and future applications in the nutritional sciences. Adv. Nutr. 2011, 2, 355-364.
88. Rabilloud, T. Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002, 2, 3-10.
89. Walther, T.C.; Mann, M. Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 2010, 190, 491-500.
90. Domon, B.; Aebersold, R. Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 2010, 28, 710-721.
91. Norheim, F.; Raastad, T.; Thiede, B.; Rustan, A.C.; Drevon, C.A.; Haugen, F. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 2011, 301, E1013-E1021.
92. Unwin, R.D.; Griffiths, J.R.; Whetton, A.D. Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat. Protoc. 2010, 5, 1574-1582.
93. Ong, S.E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D.B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
94. Gouw, J.W.; Krijgsveld, J.; Heck, A.J. Quantitative proteomics by metabolic labeling of model organisms. Mol. Cell. Proteomics 2010, 9, 11-24.
95. Forner, F.; Kumar, C.; Luber, C.A.; Fromme, T.; Klingenspor, M.; Mann, M. Proteome differences between brown and white fat mitochondria reveal specialized metabolic functions. Cell Metab. 2009, 10, 324-335.
96. Hwang, H.; Bowen, B.P.; Lefort, N.; Flynn, C.R.; de Filippis, E.A.; Roberts, C.; Smoke, C.C.; Meyer, C.; Hojlund, K.; Yi, Z.; Mandarino, L.J. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010, 59, 33-42.
97. Schwer, B.; Eckersdorff, M.; Li, Y.; Silva, J.C.; Fermin, D.; Kurtev, M.V.; Giallourakis, C.; Comb, M.J.; Alt, F.W.; Lombard, D.B. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8, 604-606.
98. Picotti, P.; Aebersold, R. Selected reaction monitoring-based proteomics: Workflows, potential, pitfalls and future directions. Nat. Methods 2012, 9, 555-566.
99. Patti, G.J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: The apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 2012, 13, 263-269.
100. Aune, D.; Chan, D.S.; Vieira, A.R.; Navarro Rosenblatt, D.A.; Vieira, R.; Greenwood, D.C.; Norat, T. Dietary compared with blood concentrations of carotenoids and breast cancer risk: A systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2012, 96, 356-373.
101. Gibney, M.J.; Walsh, M.; Brennan, L.; Roche, H.M.; German, B.; van Ommen, B. Metabolomics in human nutrition: Opportunities and challenges. Am. J. Clin. Nutr. 2005, 82, 497-503.
102. Lodge, J.K. Symposium 2: Modern approaches to nutritional research challenges: Targeted and non-targeted approaches for metabolite profiling in nutritional research. Proc. Nutr. Soc 2010, 69, 95-102.
103. Zhang, A.; Sun, H.; Wang, P.; Han, Y.; Wang, X. Modern analytical techniques in metabolomics analysis. Analyst 2012, 137, 293-300.
104. Griffiths, W.J.; Koal, T.; Wang, Y.; Kohl, M.; Enot, D.P.; Deigner, H.P. Targeted metabolomics for biomarker discovery. Angew. Chem. Int. Ed. Engl. 2010, 49, 5426-5445.
105. Karlsen, A.; Svendsen, M.; Seljeflot, I.; Sommernes, M.A.; Sexton, J.; Brevik, A.; Erlund, I.; Serafini, M.; Bastani, N.; Remberg, S.F. et al. Compliance, tolerability and safety of two antioxidant-rich diets: A randomised controlled trial in male smokers. Br. J. Nutr. 2011, 106, 557-571.
106. German, J.B.; Gillies, L.A.; Smilowitz, J.T.; Zivkovic, A.M.; Watkins, S.M. Lipidomics and lipid profiling in metabolomics. Curr. Opin. Lipidol. 2007, 18, 66-71.
107. Karlsen, A.; Retterstol, L.; Laake, P.; Paur, I.; Bohn, S.K.; Sandvik, L.; Blomhoff, R. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J. Nutr. 2007, 137, 1951-1954.
108. Karlsen, A.; Paur, I.; Bohn, S.K.; Sakhi, A.K.; Borge, G.I.; Serafini, M.; Erlund, I.; Laake, P.; Tonstad, S.; Blomhoff, R. Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur. J. Nutr. 2010, 49, 345-355.
109. Brevik, A.; Karlsen, A.; Azqueta, A.; Tirado, A.E.; Blomhoff, R.; Collins, A. Both base excision repair and nucleotide excision repair in humans are influenced by nutritional factors. Cell Biochem. Funct. 2011, 29, 36-42.
110. Brevik, A.; Gaivao, I.; Medin, T.; Jorgenesen, A.; Piasek, A.; Elilasson, J.; Karlsen, A.; Blomhoff, R.; Veggan, T.; Duttaroy, A.K.; Collins, A.R. Supplementation of a western diet with golden kiwifruits (Actinidia chinensis var. 'Hort 16A':) effects on biomarkers of oxidation damage and antioxidant protection. Nutr. J. 2011, 10, 54.
111. Puri, R.; Duong, M.; Uno, K.; Kataoka, Y.; Nicholls, S.J. The emerging role of plasma lipidomics in cardiovascular drug discovery. Expert Opin. Drug Discov. 2012, 7, 63-72.
112. Wood, P.L. Lipidomics of Alzheimer's disease: Current status. Alzheimers Res. Ther. 2012, 4, 5.
113. Wittwer, J.; Rubio-Aliaga, I.; Hoeft, B.; Bendik, I.; Weber, P.; Daniel, H. Nutrigenomics in human intervention studies: Current status, lessons learned and future perspectives. Mol. Nutr. Food Res. 2011, 55, 341-358.
114. Bocci, V. The neglected organ: Bacterial flora has a crucial immunostimulatory role. Perspect. Biol. Med. 1992, 35, 251-260.
115. Backhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915-1920.
116. Nicholson, J.K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions. Science 2012, 336, 1262-1267.
117. Hooper, L.V.; Littman, D.R.; Macpherson, A.J. Interactions between the microbiota and the immune system. Science 2012, 336, 1268-1273.
118. Suau, A.; Bonnet, R.; Sutren, M.; Godon, J.J.; Gibson, G.R.; Collins, M.D.; Dore, J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 1999, 65, 4799-4807.
119. Zoetendal, E.G.; Rajilic-Stojanovic, M.; de Vos, W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57, 1605-1615.
120. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207-214.
121. Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780-13785.
122. Tap, J.; Mondot, S.; Levenez, F.; Pelletier, E.; Caron, C.; Furet, J.P.; Ugarte, E.; Munoz-Tamayo, R.; Paslier, D.L.; Nalin, R. et al. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 2009, 11, 2574-2584.
123. Gill, S.R.; Pop, M.; Deboy, R.T.; Eckburg, P.B.; Turnbaugh, P.J.; Samuel, B.S.; Gordon, J.I.; Relman, D.A.; Fraser-Liggett, C.M.; Nelson, K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312, 1355-1359.
124. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59-65.
125. Dutton, R.J.; Turnbaugh, P.J. Taking a metagenomic view of human nutrition. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 448-454.
126. Wu, G.D.; Chen, J.; Hoffmann, C.; Bittinger, K.; Chen, Y.Y.; Keilbaugh, S.A.; Bewtra, M.; Knights, D.; Walters, W.A.; Knight, R. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105-108.
127. Walker, A.W.; Ince, J.; Duncan, S.H.; Webster, L.M.; Holtrop, G.; Ze, X.; Brown, D.; Stares, M.D.; Scott, P.; Bergerat, A. et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220-230.
128. Davis, L.M.; Martinez, I.; Walter, J.; Goin, C.; Hutkins, R.W. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011, 6, e25200.
129. Ramirez-Farias, C.; Slezak, K.; Fuller, Z.; Duncan, A.; Holtrop, G.; Louis, P. Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101, 541-550.
130. Flint, H.J.; Scott, K.P.; Louis, P.; Duncan, S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 577-589.
131. Weissleder, R.; Pittet, M.J. Imaging in the era of molecular oncology. Nature 2008, 452, 580-589.
132. Heymsfield, S.B. Development of imaging methods to assess adiposity and metabolism. Int. J. Obes. (Lond.) 2008, 32, S76-S82.
133. Rokling-Andersen, M.H.; Rustan, A.C.; Wensaas, A.J.; Kaalhus, O.; Wergedahl, H.; Rost, T.H.; Jensen, J.; Graff, B.A.; Caesar, R.; Drevon, C.A. Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet. Br. J. Nutr. 2009, 102, 995-1006.
134. Wensaas, A.J.; Rustan, A.C.; Rokling-Andersen, M.H.; Caesar, R.; Jensen, J.; Kaalhus, O.; Graff, B.A.; Gudbrandsen, O.A.; Berge, R.K.; Drevon, C.A. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes Obes. Metab. 2009, 11, 1034-1049.
135. Seidell, J.C.; Bakker, C.J.; van der Kooy, K. Imaging techniques for measuring adipose-tissue distribution-A comparison between computed tomography and 1.5-T magnetic resonance. Am. J. Clin. Nutr. 1990, 51, 953-957.
136. Klopfenstein, B.J.; Kim, M.S.; Krisky, C.M.; Szumowski, J.; Rooney, W.D.; Purnell, J.Q. Comparison of 3-T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br. J. Radiol. 2012, 85, e826-e830.
137. Gray, C.; MacGillivray, T.J.; Eeley, C.; Stephens, N.A.; Beggs, I.; Fearon, K.C.; Greig, C.A. Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia. Clin. Nutr. 2011, 30, 106-111.
138. Kielland, A.; Carlsen, H. Molecular imaging of transcriptional regulation during inflammation. J. Inflamm. (Lond.) 2010, 7, 20.
139. Paur, I.; Balstad, T.R.; Kolberg, M.; Pedersen, M.K.; Austenaa, L.M.; Jacobs, D.R., Jr.; Blomhoff, R. Extract of oregano, coffee, thyme, clove, and walnuts inhibits NF-kappaB in monocytes and in transgenic reporter mice. Cancer Prev. Res. (Phila.) 2010, 3, 653-663.
140. Zhang, Y.; Proenca, R.; Maffei, M.; Barone, M.; Leopold, L.; Friedman, J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372, 425-432.
141. Kaiyala, K.J.; Ramsay, D.S. Direct animal calorimetry, the underused gold standard for quantifying the fire of life. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2011, 158, 252-264.
142. Levine, J.A. Measurement of energy expenditure. Public Health Nutr. 2005, 8, 1123-1132.
143. Tschop, M.H.; Speakman, J.R.; Arch, J.R.; Auwerx, J.; Bruning, J.C.; Chan, L.; Eckel, R.H.; Farese, R.V., Jr.; Galgani, J.E.; Hambly, C. et al. A guide to analysis of mouse energy metabolism. Nat. Methods 2012, 9, 57-63.
144. Butler, A.A.; Kozak, L.P. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 2010, 59, 323-329.
145. Azuaje, F.; Devaux, Y.; Wagner, D. Computational biology for cardiovascular biomarker discovery. Brief. Bioinform. 2009, 10, 367-377.
146. Ng, A.; Bursteinas, B.; Gao, Q.; Mollison, E.; Zvelebil, M. Resources for integrative systems biology: From data through databases to networks and dynamic system models. Brief. Bioinform. 2006, 7, 318-330.
147. Evelo, C.T.; van Bochove, K.; Saito, J.T. Answering biological questions: Querying a systems biology database for nutrigenomics. Genes Nutr. 2011, 6, 81-87.
148. Hester, R.L.; Iliescu, R.; Summers, R.; Coleman, T.G. Systems biology and integrative physiological modelling. J. Physiol. 2011, 589, 1053-1060.
149. Frayn, K.N. Metabolic Regulation: A Human Perspective. In Metabolic Regulation: A Human Perspective; Wiley-Blackwell: Oxford, UK, 2010.
150. Rosen, E.D.; Spiegelman, B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444, 847-853.
151. Matsuzawa, Y.; Funahashi, T.; Nakamura, T. The concept of metabolic syndrome: Contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 2011, 18, 629-639.
152. Fox, C.S.; Liu, Y.; White, C.C.; Feitosa, M.; Smith, A.V.; Heard-Costa, N.; Lohman, K.; Johnson, A.D.; Foster, M.C.; Greenawalt, D.M. et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 2012, 8, e1002695.
153. Vinknes, K.J.; Elshorbagy, A.K.; Drevon, C.A.; Gjesdal, C.G.; Tell, G.S.; Nygård, O.; Vollset, S.E.; Refsum, H. Evaluation of the Body Adiposity Index in a Caucasian Population. The Hordaland Health Study. Am. J. Epidemiol. 2012, in press.
154. Canoy, D. Coronary heart disease and body fat distribution. Curr. Atheroscler. Rep. 2010, 12, 125-133.
155. Heitmann, B.L.; Lissner, L. Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes. Rev. 2011, 12, 478-481.
156. Gesta, S.; Tseng, Y.H.; Kahn, C.R. Developmental origin of fat: Tracking obesity to its source. Cell 2007, 131, 242-256.
157. Cinti, S. Transdifferentiation properties of adipocytes in the adipose organ. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E977-E986.
158. Bjorneboe, A.; Bjorneboe, G.E.; Drevon, C.A. Absorption, transport and distribution of vitamin E. J. Nutr. 1990, 120, 233-242.
159. Pond, C.M. Adipose tissue and the immune system. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73, 17-30.
160. Knittle, J.L.; Timmers, K.; Ginsberg-Fellner, F.; Brown, R.E.; Katz, D.P. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J. Clin. Invest. 1979, 63, 239-246.
161. Seale, P.; Bjork, B.; Yang, W.; Kajimura, S.; Chin, S.; Kuang, S.; Scime, A.; Devarakonda, S.; Conroe, H.M.; Erdjument-Bromage, H. et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454, 961-967.
162. Virtanen, K.A.; Lidell, M.E.; Orava, J.; Heglind, M.; Westergren, R.; Niemi, T.; Taittonen, M.; Laine, J.; Savisto, N.J.; Enerback, S.; Nuutila, P. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 2009, 360, 1518-1525.
163. Cypess, A.M.; Lehman, S.; Williams, G.; Tal, I.; Rodman, D.; Goldfine, A.B.; Kuo, F.C.; Palmer, E.L.; Tseng, Y.H.; Doria, A. et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360, 1509-1517.
164. Van Marken Lichtenbelt, W.D.; Vanhommerig, J.W.; Smulders, N.M.; Drossaerts, J.M.; Kemerink, G.J.; Bouvy, N.D.; Schrauwen, P.; Teule, G.J. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360, 1500-1508.
165. Saito, M.; Okamatsu-Ogura, Y.; Matsushita, M.; Watanabe, K.; Yoneshiro, T.; Nio-Kobayashi, J.; Iwanaga, T.; Miyagawa, M.; Kameya, T.; Nakada, K. et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: Effects of cold exposure and adiposity. Diabetes 2009, 58, 1526-1531.
166. Kajimura, S.; Seale, P.; Kubota, K.; Lunsford, E.; Frangioni, J.V.; Gygi, S.P.; Spiegelman, B.M. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009, 460, 1154-1158.
167. Ahfeldt, T.; Schinzel, R.T.; Lee, Y.K.; Hendrickson, D.; Kaplan, A.; Lum, D.H.; Camahort, R.; Xia, F.; Shay, J.; Rhee, E.P. et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol. 2012, 14, 209-219.
168. Spalding, K.L.; Arner, E.; Westermark, P.O.; Bernard, S.; Buchholz, B.A.; Bergmann, O.; Blomqvist, L.; Hoffstedt, J.; Naslund, E.; Britton, T. et al. Dynamics of fat cell turnover in humans. Nature 2008, 453, 783-787.
169. Arner, P.; Bernard, S.; Salehpour, M.; Possnert, G.; Liebl, J.; Steier, P.; Buchholz, B.A.; Eriksson, M.; Arner, E.; Hauner, H. et al. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 2011, 478, 110-113.
170. G. Histogenesis, Section 5: Adipose Tissue; American Physiological Society: Washington, DC, USA, 1965.
171. Tang, W.; Zeve, D.; Suh, J.M.; Bosnakovski, D.; Kyba, M.; Hammer, R.E.; Tallquist, M.D.; Graff, J.M. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322, 583-586.
172. Rodeheffer, M.S.; Birsoy, K.; Friedman, J.M. Identification of white adipocyte progenitor cells in vivo. Cell 2008, 135, 240-249.
173. Tran, K.V.; Gealekman, O.; Frontini, A.; Zingaretti, M.C.; Morroni, M.; Giordano, A.; Smorlesi, A.; Perugini, J.; de Matteis, R.; Sbarbati, A. et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab. 2012, 15, 222-229.
174. Gupta, R.K.; Mepani, R.J.; Kleiner, S.; Lo, J.C.; Khandekar, M.J.; Cohen, P.; Frontini, A.; Bhowmick, D.C.; Ye, L.; Cinti, S.; Spiegelman, B.M. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab. 2012, 15, 230-239.
175. Drevon, C.A. Fatty acids and expression of adipokines. Biochim. Biophys. Acta 2005, 1740, 287-292.
176. Skurk, T.; Alberti-Huber, C.; Herder, C.; Hauner, H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007, 92, 1023-1033.
177. Haugen, F.; Zahid, N.; Dalen, K.T.; Hollung, K.; Nebb, H.I.; Drevon, C.A. Resistin expression in 3T3-L1 adipocytes is reduced by arachidonic acid. J. Lipid Res. 2005, 46, 143-153.
178. DeFronzo, R.A.; Jacot, E.; Jequier, E.; Maeder, E.; Wahren, J.; Felber, J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981, 30, 1000-1007.
179. Jensen, J.; Rustad, P.I.; Kolnes, A.J.; Lai, Y.C. The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise. Front. Physiol. 2011, 2, 112.
180. Jensen, J.; Ruge, T.; Lai, Y.C.; Svensson, M.K.; Eriksson, J.W. Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle. Metabolism 2011, 60, 215-226.
181. Ruderman, N.B.; Xu, X.J.; Nelson, L.; Cacicedo, J.M.; Saha, A.K.; Lan, F.; Ido, Y. AMPK and SIRT1: A long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 2010, 298, E751-E760.
182. Narkar, V.A.; Downes, M.; Yu, R.T.; Embler, E.; Wang, Y.X.; Banayo, E.; Mihaylova, M.M.; Nelson, M.C.; Zou, Y.; Juguilon, H. et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008, 134, 405-415.
183. Alibegovic, A.C.; Sonne, M.P.; Hojbjerre, L.; Bork-Jensen, J.; Jacobsen, S.; Nilsson, E.; Faerch, K.; Hiscock, N.; Mortensen, B.; Friedrichsen, M. et al. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E752-E763.
184. Giebelstein, J.; Poschmann, G.; Hojlund, K.; Schechinger, W.; Dietrich, J.W.; Levin, K.; Beck-Nielsen, H.; Podwojski, K.; Stuhler, K.; Meyer, H.E.; Klein, H.H. The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes. Diabetologia 2012, 55, 1114-1127.
185. Rowlands, D.S.; Thomson, J.S.; Timmons, B.W.; Raymond, F.; Fuerholz, A.; Mansourian, R.; Zwahlen, M.C.; Metairon, S.; Glover, E.; Stellingwerff, T. et al. Transcriptome and translational signaling following endurance exercise in trained skeletal muscle: Impact of dietary protein. Physiol. Genomics 2011, 43, 1004-1020.
186. Van Loon, L.J.; Greenhaff, P.L.; Constantin-Teodosiu, D.; Saris, W.H.; Wagenmakers, A.J. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J. Physiol. 2001, 536, 295-304.
187. Aas, V.; Kase, E.T.; Solberg, R.; Jensen, J.; Rustan, A.C. Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 2004, 47, 1452-1461.
188. Dresner, A.; Laurent, D.; Marcucci, M.; Griffin, M.E.; Dufour, S.; Cline, G.W.; Slezak, L.A.; Andersen, D.K.; Hundal, R.S.; Rothman, D.L. et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 1999, 103, 253-259.
189. Helge, J.W.; Kiens, B. Muscle enzyme activity in humans: Role of substrate availability and training. Am. J. Physiol. 1997, 272, R1620-R1624.
190. Pedersen, B.K.; Febbraio, M.A. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol. Rev. 2008, 88, 1379-1406.
191. McPherron, A.C.; Lawler, A.M.; Lee, S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387, 83-90.
192. Ostrowski, K.; Rohde, T.; Zacho, M.; Asp, S.; Pedersen, B.K. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J. Physiol. 1998, 508, 949-953.
193. Haugen, F.; Norheim, F.; Lian, H.; Wensaas, A.J.; Dueland, S.; Berg, O.; Funderud, A.; Skalhegg, B.S.; Raastad, T.; Drevon, C.A. IL-7 is expressed and secreted by human skeletal muscle cells. Am. J. Physiol. Cell Physiol. 2010, 298, C807-C816.
194. Nielsen, A.R.; Hojman, P.; Erikstrup, C.; Fischer, C.P.; Plomgaard, P.; Mounier, R.; Mortensen, O.H.; Broholm, C.; Taudorf, S.; Krogh-Madsen, R. et al. Association between interleukin-15 and obesity: Interleukin-15 as a potential regulator of fat mass. J. Clin. Endocrinol. Metab. 2008, 93, 4486-4493.
195. Nitert, M.D.; Dayeh, T.; Volkov, P.; Elgzyri, T.; Hall, E.; Nilsson, E.; Yang, B.T.; Lang, S.; Parikh, H.; Wessman, Y. et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 2012, doi:10.2337/db11-1653.
196. Bostrom, P.; Wu, J.; Jedrychowski, M.P.; Korde, A.; Ye, L.; Lo, J.C.; Rasbach, K.A.; Bostrom, E.A.; Choi, J.H.; Long, J.Z. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481, 463-468.
197. Vallim, T.; Salter, A.M. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82, 211-218.
198. Krawczyk, M.; Bonfrate, L.; Portincasa, P. Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 2010, 24, 695-708.
199. Takamura, T.; Misu, H.; Ota, T.; Kaneko, S. Fatty liver as a consequence and cause of insulin resistance: Lessons from type 2 diabetic liver. Endocr. J. 2012, 59, 745-763.
200. Thomas, E.L.; Parkinson, J.R.; Frost, G.S.; Goldstone, A.P.; Dore, C.J.; McCarthy, J.P.; Collins, A.L.; Fitzpatrick, J.A.; Durighel, G.; Taylor-Robinson, S.D.; Bell, J.D. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 2012, 20, 76-87.
201. Chalasani, N.; Younossi, Z.; Lavine, J.E.; Diehl, A.M.; Brunt, E.M.; Cusi, K.; Charlton, M.; Sanyal, A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55, 2005-2023.
202. Valenzuela, R.; Videla, L.A. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct. 2011, 2, 644-648.
203. Bjermo, H.; Iggman, D.; Kullberg, J.; Dahlman, I.; Johansson, L.; Persson, L.; Berglund, J.; Pulkki, K.; Basu, S.; Uusitupa, M. et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 95, 1003-1012.
204. Farese, R.V., Jr.; Zechner, R.; Newgard, C.B.; Walther, T.C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 2012, 15, 570-573.
205. Misu, H.; Takamura, T.; Takayama, H.; Hayashi, H.; Matsuzawa-Nagata, N.; Kurita, S.; Ishikura, K.; Ando, H.; Takeshita, Y.; Ota, T. et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 2010, 12, 483-495.
206. Tierney, A.C.; McMonagle, J.; Shaw, D.I.; Gulseth, H.L.; Helal, O.; Saris, W.H.; Paniagua, J.A.; Golabek-Leszczynska, I.; Defoort, C.; Williams, C.M. et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: A European randomized dietary intervention study. Int. J. Obes. (Lond.) 2011, 35, 800-809.
207. Brevik, A.; Andersen, L.F.; Karlsen, A.; Trygg, K.U.; Blomhoff, R.; Drevon, C.A. Six carotenoids in plasma used to assess recommended intake of fruits and vegetables in a controlled feeding study. Eur. J. Clin. Nutr. 2004, 58, 1166-1173.
208. Andersen, L.F.; Solvoll, K.; Drevon, C.A. Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am. J. Clin. Nutr. 1996, 64, 305-311.
209. Singh, B.; Saxena, A. Surrogate markers of insulin resistance: A review. World J. Diabetes 2010, 1, 36-47.
210. World Health Organization; International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation; World Health Organization: Geneva, Switerzland, 2006; p. 21.
211. Monzillo, L.U.; Hamdy, O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr. Rev. 2003, 61, 397-412.
212. Matsuda, M. Measuring and estimating insulin resistance in clinical and research settings. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 79-86.
213. Lorenzo, C.; Hazuda, H.P.; Haffner, S.M. Insulin resistance and excess risk of diabetes in Mexican-Americans: The San Antonio Heart Study. J. Clin. Endocrinol. Metab. 2012, 97, 793-799.
214. Shaham, O.; Wei, R.; Wang, T.J.; Ricciardi, C.; Lewis, G.D.; Vasan, R.S.; Carr, S.A.; Thadhani, R.; Gerszten, R.E.; Mootha, V.K. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol. Syst. Biol. 2008, 4, 214.
215. Wopereis, S.; Rubingh, C.M.; van Erk, M.J.; Verheij, E.R.; van Vliet, T.; Cnubben, N.H.; Smilde, A.K.; van der Greef, J.; van Ommen, B.; Hendriks, H.F. Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS One 2009, 4, e4525.
216. Rubio-Aliaga, I.; Roos, B.; Duthie, S.; Crosley, L.; Mayer, C.; Horgan, G.; Colquhoun, I.; Gall, G.; Huber, F.; Kremer, W. et al. Metabolomics of prolonged fasting in humans reveals new catabolic markers. Metabolomics 2010, 7, 375-387.
217. Krug, S.; Kastenmuller, G.; Stuckler, F.; Rist, M.J.; Skurk, T.; Sailer, M.; Raffler, J.; Romisch-Margl, W.; Adamski, J.; Prehn, C. et al. The dynamic range of the human metabolome revealed by challenges. FASEB J. 2012, 26, 2607-2619.
218. Speakman, J.R.; Levitsky, D.A.; Allison, D.B.; Bray, M.S.; de Castro, J.M.; Clegg, D.J.; Clapham, J.C.; Dulloo, A.G.; Gruer, L.; Haw, S. et al. Set points, settling points and some alternative models: Theoretical options to understand how genes and environments combine to regulate body adiposity. Dis. Model. Mech. 2011, 4, 733-745.
219. Hession, M.; Rolland, C.; Kulkarni, U.; Wise, A.; Broom, J. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes. Rev. 2009, 10, 36-50.
220. Sacks, F.M.; Bray, G.A.; Carey, V.J.; Smith, S.R.; Ryan, D.H.; Anton, S.D.; McManus, K.; Champagne, C.M.; Bishop, L.M.; Laranjo, N. et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 2009, 360, 859-873.
221. Lagiou, P.; Sandin, S.; Lof, M.; Trichopoulos, D.; Adami, H.O.; Weiderpass, E. Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: Prospective cohort study. BMJ 2012, 344, e4026.
222. Ericson, U.; Sonestedt, E.; Gullberg, B.; Hellstrand, S.; Hindy, G.; Wirfalt, E.; Orho-Melander, M. High intakes of protein and processed meat associate with increased incidence of type 2 diabetes. Br. J. Nutr. 2012, in press.
223. Knowler, W.C.; Fowler, S.E.; Hamman, R.F.; Christophi, C.A.; Hoffman, H.J.; Brenneman, A.T.; Brown-Friday, J.O.; Goldberg, R.; Venditti, E.; Nathan, D.M. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374, 1677-1686.
224. Li, G.; Zhang, P.; Wang, J.; Gregg, E.W.; Yang, W.; Gong, Q.; Li, H.; Li, H.; Jiang, Y.; An, Y. et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet 2008, 371, 1783-1789.
225. Lindstrom, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemio, K.; Hamalainen, H.; Harkonen, P.; Keinanen-Kiukaanniemi, S.; Laakso, M. et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368, 1673-1679.
226. Helland, I.B.; Smith, L.; Saarem, K.; Saugstad, O.D.; Drevon, C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111, e39-e44.